Mortal by Design
Before the butterfly and the jellyfish, the baseline: how a normal cell copies itself, why it's built to die, and what happens when those brakes come off. By the end of this tab the rest of the lab is just two answers to one question — how do you keep dividing without becoming the thing in the bottom half of this page?
NULL does not speak. But NULL stacks one block, then two identical blocks, then four — perfect copies, perfectly boring. Then NULL pulls one block out of the stack, scribbles on it, and lets it keep copying the scribble. NULL points at the scribbled tower growing faster than all the others. NULL does not look pleased. NULL looks like a penguin who has seen this before.
Every time a cell divides it copies its chromosomes — and the protective caps on the ends, the telomeres, get a little shorter each time. That's a built-in counter: after roughly fifty divisions the caps run out, the cell stops (senescence) and usually triggers apoptosis, its own clean self-destruct. This is the Hayflick limit, and it is not a bug. A cell that can only divide fifty times is a cell that can't run away from you. Your mortality, at the cellular level, is a safety feature.
Turn on telomerase in the panel above and the caps stop shortening — the counter never runs out, the cell divides without limit. Now disable apoptosis and you've removed the self-destruct too. What you've just built has a name, and it's the same construction every time: a cancer cell is an immortal cell with the safety features cut. It is not a different kind of cell. It is a normal cell that won the worst possible lottery — endless division, no off-switch, no quality control.
The Whole Lab in One Sentence
Immortality at the cell level is easy — you've already seen how few switches it takes. The hard part is having it with the brakes on: dividing or rebuilding forever without losing the quality control that stops you becoming a tumor. The butterfly does it one way. The jellyfish does it the opposite way. Keep that one sentence in your pocket for the next three tabs.
The Maintainer
The butterfly's whole strategy is the opposite of a reset: keep the same body and never let it degrade. Roughly three times the lifespan of its closest relatives — some species stretching to nearly a year — with measurably slowed ageing, not just a longer clock.
NULL raises a party-blower. It uncoils with a wheeze, the paper tip flutters, and a puff of glitter shakes loose into NULL's cup. NULL drinks the glitter. NULL does not reset. NULL maintains. NULL has been the same penguin this entire lab.
Screen 1 · The proboscis: turning pollen into time
Most butterflies sip nectar — sugar, quick energy, no building blocks. Heliconius does what almost no other butterfly does: it collects pollen on its coiled proboscis, then spends minutes to hours coiling and uncoiling to agitate the grains in a bath of saliva, dissolving out the amino acids inside. Amino acids are protein — raw material for eggs and for the constant repair that keeps an old body working. Run the feeder: more agitation and more saliva pull more protein, and the lifespan/egg meter answers.
Why a butterfly bothers
A nectar-only relative runs on sugar and burns out in about six weeks. A pollen-feeding Heliconius keeps a steady protein supply coming for months — lifelong egg-laying and lifelong repair on the same income stream. The food is the maintenance budget.
Screen 2 · Cocoonase: a gene that changed careers
Here's the strange part — the butterfly didn't invent a new tool to dissolve pollen. It repurposed an old one. Moths hatch by spitting an enzyme called cocoonase to dissolve their way out of the cocoon. Butterflies don't make cocoons… so the gene was out of a job. Step through what evolution did with it instead of throwing it away:
The second mechanism · proteostasis
Intake is only half of it. Aged Heliconius also crank up proteostasis — the protein-folding and quality-control crew (chaperones) that catch damaged proteins before they pile up. Income (cocoonase pulls in amino acids) plus upkeep (chaperones spend them on repair). Maintenance, not reset.
Honest tag
Cocoonase is the leading candidate for the pollen-dissolving enzyme — it's duplicated into multiple copies and switched on in the proboscis exactly where you'd want it. Its precise role in digestion is still officially undemonstrated. Strong lead, not a closed case.
Back to the spine
The butterfly is immortal-ish with the brakes fully on. It never switches off apoptosis, never flips a master immortality switch, never resets to an earlier save-point. It just refuses to degrade. That's the safe way to cheat the clock — and it's the exact opposite of what the jellyfish does next.
Sources: Foley et al., Nature Communications 2026 · cocoonase gene duplication, Genome Biol. Evol. 2016 · pollen-feeding delays senescence, Peer Community Journal 2024.
The Resetter
The immortal jellyfish does the other thing entirely: it lets the body wear out, then throws it back to an earlier save point — gathering the good stuff first.
The whole tab in one object: the box
When Turritopsis resets, it doesn't start from nothing. It carries its quality-control machinery — DNA repair, telomere upkeep, the genes that keep division honest — down into the new body like a treasure box. Toggle whether it brings the box, trigger the reset, and watch the two endings.
What the box really is
Under the metaphor: Turritopsis dohrnii reverses its life cycle by transdifferentiation — mature cells switch identity. Its genome carries expanded DNA-repair and telomere-maintenance genes, can silence Polycomb repressors, and can switch pluripotency factors back on. The "box" is that prioritized quality-control toolkit: it reprograms and keeps the brakes. (Honest note: the comparison-genome study has been contested — the rejuvenation mechanism is real, the sister-species comparison is debated.)
This is the Tab I cliff, paid off
Remember the uncomfortable sentence: a cancer cell and an immortal cell are built the same way. Here it is in motion. Reset with the box = jellyfish. The exact same reset without the box = cancer. Going young again was never the danger. Doing it without the brakes is.
Sources: Pascual-Torner et al., PNAS 2022 (comparative genomics of Turritopsis dohrnii; expanded DNA-repair & telomere genes) · Miglietta critique, 2023.
The Human Bet
Two animals, two strategies, billions of dollars split between them. Which one is the bet — and where's the line between inspiration and a tumor?
NULL sets two jars on the bench — one labeled MAINTAIN, one labeled RESET — and looks at the billions of dollars piled behind each. NULL does not pick a jar. NULL suspects the jar is the wrong question.
Two animals, two human industries
Everything the longevity field is trying splits along the line you just watched. One camp copies the butterfly: maintain the body you have. The other copies the jellyfish: reset it. Billions are split between them — and both run straight at the same wall.
The promise: conservative — you never touch a cell's identity, so you stay far from the cancer cliff.
The danger: it may only slow the slide, not reverse it — and even "just" clearing cells leans on the brakes, the safety you must not break.
The promise: real reversal of aging features has been shown in animals.
The danger: it's the jellyfish move — and the jellyfish needs the box. Reprogramming a human cell is one slipped gear from leaving the box on the dock. This whole lab is the warning: reset without the brakes is cancer.
The danger is always the same word
Maintain or reset, the wall both camps run at is the brakes. Every gain in this field is really a question about quality control: can you push cells to last longer or grow younger without cutting the safety that stops them becoming a tumor? Immortality was never the hard part. It still isn't.
Real / mine · the load-bearing line
The butterfly and the jellyfish are real, and really do this. They are inspiration, not therapy. Nothing here is a treatment, a protocol, or a promise that any of it will work in people. The science is the hook; the honesty is the point. Full sources are in .
Sources: Ocampo et al., Cell 2016 (in-vivo partial reprogramming with Yamanaka factors).